NeoChord

NeoChord, founded in 2007 and headquartered in St. Louis Park, Minnesota, USA, is a privately-held medical technology company dedicated to advancing minimally invasive repair techniques for degenerative mitral regurgitation (DMR). The company’s flagship product is the DS1000 artificial chordae delivery system, a single-use, hand-held device that enables mitral valve repair through a 2 to 3-inch incision between the patient’s ribs on a beating heart, without the need for cardiopulmonary bypass or aortic occlusion.